GBA rs145465715: Understanding Genetic Risk and Parkinson's

What each genotype means

What is the rs145465715 Variant?

The rs145465715 variant is a single nucleotide polymorphism (SNP) found within the GBA gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is classified as a missense mutation, meaning the change in the DNA code results in the production of a different amino acid during the synthesis of the GBA protein. Because the GBA gene is critical for cellular health, researchers monitor such variants to understand how they might alter protein function. While many variants in the human genome are benign, those in the GBA gene are of particular interest to the scientific community due to their established links to lysosomal storage disorders and neurodegenerative conditions. This variant is currently cataloged in major genetic databases, though its specific functional impact is still being characterized by ongoing clinical research.

The Role of the GBA Gene

The GBA gene provides instructions for producing an enzyme called glucocerebrosidase (GCase). This enzyme is located in lysosomes, which are the recycling centers of the cell. GCase is responsible for breaking down a fatty substance called glucocerebroside into simpler molecules that the cell can reuse. When the GBA gene contains certain variants, the resulting GCase enzyme may be misfolded or have reduced activity. This can lead to the accumulation of glucocerebroside within cells, which is the underlying cause of Gaucher disease, an autosomal recessive condition. Beyond Gaucher disease, research has consistently shown that individuals who carry even a single variant in the GBA gene may have an altered risk profile for developing Parkinson's disease. The enzyme's role in maintaining lipid homeostasis is thought to be a key factor in why these genetic changes can influence long-term neurological health.

Research and Evidence Strength

The association between GBA variants and Parkinson's disease is a major area of study in neurology. While some GBA mutations are well-documented as pathogenic for Gaucher disease, the link between specific variants like rs145465715 and Parkinson's disease is often described as having limited or evolving evidence. Large-scale studies have observed that GBA variant carriers are overrepresented in Parkinson's disease cohorts compared to the general population. However, it is important to note that carrying a variant does not guarantee the development of a disease. The evidence is often ancestry-specific, and the degree of risk can vary significantly depending on the specific mutation. Because the field is rapidly evolving, some associations previously thought to be strong are being re-evaluated with larger datasets. Researchers emphasize that GBA-associated Parkinson's may present with slightly different clinical features, such as an earlier age of onset or a higher likelihood of non-motor symptoms.

Population Frequency

The frequency of GBA variants is highly dependent on ancestral background. For the rs145465715 variant, current data indicates a low frequency, approximately 0.05% in non-Finnish European populations. In contrast, other more common GBA variants show much higher prevalence in specific groups, such as the Ashkenazi Jewish population, where carrier rates for certain mutations can reach 10% to 31%. Because this variant is relatively rare, large-scale population studies are required to accurately estimate its prevalence across diverse global ancestries. Understanding these frequency differences is essential for researchers to determine whether a variant's impact is consistent across different ethnic groups or if it is unique to specific populations.

What This Information Means for You

Genetic information regarding GBA variants is complex and should be interpreted with caution. If you have received results indicating you carry this variant, it is important to understand that this is not a medical diagnosis. Many people carry genetic variants without ever developing the associated conditions. This information is primarily used for research purposes to better understand disease mechanisms. You cannot use this information to predict your health future with certainty, nor should it be used to make personal medical decisions. If you are concerned about your risk for Parkinson's disease or Gaucher disease, the most appropriate step is to consult with a genetic counselor or a neurologist. They can provide context based on your personal and family medical history, which is often more predictive than a single genetic variant alone.

Frequently asked questions

Sources & further reading

Related variants in GBA